PD-1 on T cells and PD-L1 on the tumor cells or antigen-presenting cells can bind and lead to decreased T-cell activation, apoptosis, inhibition of cytokines, antigen tolerance, and even allow SCLC tumor cells to evade immune surveillance [69]. Here, CD274 is linked to neoplasm.